Page 92 - Read Online

Thomas et al. J Transl Genet Genom 2024;8:249-77 https://dx.doi.org/10.20517/jtgg.2024.15 Page 269

30. Simons BW, Hurley PJ, Huang Z, et al. Wnt signaling though beta-catenin is required for prostate lineage specification. Dev Biol
2012;371:246-55. DOI PubMed PMC
31. Farnsworth WE. Prostate stroma: physiology. Prostate 1999;38:60-72. DOI
32. Mostofi FK, Sesterhenn IA, Davis CJ. A pathologist's view of prostatic carcinoma. Cancer 1993;71:906-32. DOI PubMed
33. Steukers L, Glorieux S, Vandekerckhove AP, Favoreel HW, Nauwynck HJ. Diverse microbial interactions with the basement
membrane barrier. Trends Microbiol 2012;20:147-55. DOI PubMed PMC
34. Brekken RA, Stupack D. Extracellular matrix in tumor biology. In: Biology of extracellular matrix. Cham: Springer International
Publishing; 2017. DOI
35. Welén K, Damber JE. Androgens, aging, and prostate health. Rev Endocr Metab Disord 2022;23:1221-31. DOI PubMed PMC
36. Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging 2008;3:25-
44. DOI
37. Prins GS, Huang L, Birch L, Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann N Y Acad
Sci 2006;1089:1-13. DOI PubMed PMC
38. Shapiro E, Huang H, Masch RJ, McFadden DE, Wilson EL, Wu XR. Immunolocalization of estrogen receptor alpha and beta in
human fetal prostate. J Urol 2005;174:2051-3. DOI PubMed
39. Prins GS, Korach KS. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008;73:233-44.
DOI PubMed PMC
40. Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990;17:461-75. DOI
PubMed
41. Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW. The role of the androgen receptor in prostate
development and benign prostatic hyperplasia: a review. Asian J Urol 2020;7:191-202. DOI PubMed PMC
42. Schulze H, Claus S. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry.
Prostate 1990;16:331-43. DOI PubMed
43. Schulze H, Barrack ER. Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract
and prostate. Endocrinology 1987;121:1773-83. DOI PubMed
44. Prins GS, Birch L. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate
lobes. Endocrinology 1997;138:1801-9. DOI PubMed
45. Yu Y, Liu L, Xie N, et al. Expression and function of the progesterone receptor in human prostate stroma provide novel insights to
cell proliferation control. J Clin Endocrinol Metab 2013;98:2887-96. DOI PubMed PMC
46. Arora VK, Schenkein E, Murali R, et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor
blockade. Cell 2013;155:1309-22. DOI PubMed PMC
47. Tuong ZK, Loudon KW, Berry B, et al. Resolving the immune landscape of human prostate at a single-cell level in health and cancer.
Cell Rep 2021;37:110132. DOI PubMed PMC
48. Henry GH, Malewska A, Joseph DB, et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep
2018;25:3530-3542.e5. DOI PubMed PMC
49. Mass E, Ballesteros I, Farlik M, et al. Specification of tissue-resident macrophages during organogenesis. Science 2016;353:aaf4238.
DOI PubMed PMC
50. Costello LC, Franklin RB. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its
implications in prostate cancer. Arch Biochem Biophys 2016;611:100-12. DOI PubMed PMC
51. Singh KK, Desouki MM, Franklin RB, Costello LC. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant
human prostate tissues. Mol Cancer 2006;5:14. DOI PubMed PMC
52. Ginhoux F, Guilliams M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 2016;44:439-49. DOI PubMed
53. Cannarella R, Condorelli RA, Barbagallo F, La Vignera S, Calogero AE. Endocrinology of the aging prostate: current concepts. Front
Endocrinol 2021;12:554078. DOI PubMed PMC
54. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men:
longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98. DOI
55. O'Donnell AB, Araujo AB, McKinlay JB. The health of normally aging men: The massachusetts male aging study (1987-2004). Exp
Gerontol 2004;39:975-84. DOI PubMed
56. Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl
2014;16:192-202. DOI PubMed PMC
57. Rastrelli G, Vignozzi L, Corona G, Maggi M. Testosterone and benign prostatic hyperplasia. Sex Med Rev 2019;7:259-71. DOI
PubMed
58. Vignozzi L, Cellai I, Santi R, et al. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia
cells. J Endocrinol 2012;214:31-43. DOI
59. Ho CH, Fan CK, Yu HJ, et al. Testosterone suppresses uropathogenic escherichia coli invasion and colonization within prostate cells
and inhibits inflammatory responses through JAK/STAT-1 signaling pathway. PLoS One 2017;12:e0180244. DOI PubMed PMC
60. Quintar AA, Gonçalves BF, Taboga SR, Maldonado CA. The mongolian gerbil (meriones unguiculatus) as a model for inflammation-
promoted prostate carcinogenesis. Cell Biol Int 2017;41:1234-8. DOI
61. Cohen PG. Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis. Med Hypotheses